首页> 外文OA文献 >PIN24 IMPROVEMENT IN PATIENT-REPORTED DEPRESSION IN HIV+ PATIENTS EXPERIENCING GRADE 2 SIDE EFFECTS AFTER SUBSTITUTION OF THEIR PROTEASE INHIBITOR (PI)/NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR (NNRTI) WITH LOPINAVIR/RITONAVIR (LPV/R)

【2h】

PIN24 IMPROVEMENT IN PATIENT-REPORTED DEPRESSION IN HIV+ PATIENTS EXPERIENCING GRADE 2 SIDE EFFECTS AFTER SUBSTITUTION OF THEIR PROTEASE INHIBITOR (PI)/NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR (NNRTI) WITH LOPINAVIR/RITONAVIR (LPV/R)

机译：在用蛋白酶抑制剂（PI）/非核苷逆转录酶抑制剂（NNRTI）替代洛匹那韦/利托奈韦（LPV / R）的蛋白酶抑制剂（PI）/非核苷逆转录酶抑制剂（NNV）替代品后，经验丰富的HIV +患者在患者报告的抑郁症中的PIN24改善

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Luo MP; Shen Y; McMillan F; Sylte J; Ashraf T; Rode R;
展开▼
作者单位

展开▼
年度 2004
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Pharmacokinetics of high-dose lopinavir-ritonavir with and without saquinavir or nonnucleoside reverse transcriptase inhibitors in human immunodeficiency virus-infected pediatric and adolescent patients previously treated with protease inhibitors. [J] . Robbins BL, Capparelli EV, Chadwick EG, Antimicrobial agents and chemotherapy. . 2008,第9期

机译：含或不含沙奎那韦或非核苷逆转录酶抑制剂的大剂量洛匹那韦-利托那韦在先前用蛋白酶抑制剂治疗的人类免疫缺陷病毒感染的儿童和青少年患者中的药代动力学。
2. Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV-infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitors. [J] . Chetchotisakd P, Anunnatsiri S, Mootsikapun P, HIV medicine . 2007,第8期

机译：双重增强蛋白酶抑制剂（洛匹那韦+沙奎那韦/利托那韦）方案在HIV感染的非核苷类逆转录酶抑制剂治疗失败的患者中的疗效和耐受性。
3. Nucleoside reverse transcriptase inhibitor-sparing regimen (nonnucleoside reverse transcriptase inhibitor + protease inhibitor) was more likely associated with resistance comparing to nonnucleoside reverse transcriptase inhibitor or protease inhibitor + nucleoside reverse transcriptase inhibitor in the randomized ANRS 121 trial. [J] . Soulie C, Assoumou L, Ghosn J AIDS . 2009,第12期

机译：在随机ANRS 121试验中，与非核苷类逆转录酶抑制剂或蛋白酶抑制剂+核苷类逆转录酶抑制剂相比，保留核苷类逆转录酶抑制剂的方案（非核苷类逆转录酶抑制剂+蛋白酶抑制剂）更可能与耐药相关。
4. The effects of nonnucleoside reverse transcriptase inhibitor resistance mutations on human immunodeficiency virus type 1 replication and reverse transcriptase function. [D] . Gerondelis, Peter. 2001

机译：非核苷类逆转录酶抑制剂耐药性突变对人免疫缺陷病毒1型复制和逆转录酶功能的影响。
5. Pharmacokinetics of High-Dose Lopinavir-Ritonavir with and without Saquinavir or Nonnucleoside Reverse Transcriptase Inhibitors in Human Immunodeficiency Virus-Infected Pediatric and Adolescent Patients Previously Treated with Protease Inhibitors [O] . Brian L. Robbins, Edmund V. Capparelli, Ellen G. Chadwick, 2008

机译：高剂量洛匹那韦-利托那韦在有或没有沙奎那韦或非核苷类逆转录酶抑制剂的情况下在以前用蛋白酶抑制剂治疗的人类免疫缺陷病毒感染的儿童和青少年患者中的药代动力学
6. PIN30 SUBSTITUTION TO LOPINAVIR/RITONAVIR (LPV/R) IS ASSOCIATED WITH IMPROVED PATIENT-REPORTED FATIGUE IN HIV+ PATIENTS EXPERIENCING SIDE EFFECTS RELATED TO THEIR PROTEASE INHIBITOR (PI)/NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR (NNRTI) [O] . Luo MP, Shen Y, Rode R, 2004

机译：PIN30替代洛匹那韦/利托那韦（LPV / R）与HIV +患者的蛋白酶报告的增强的患者报告疲劳有关，其蛋白酶抑制剂（PI）/非核苷逆转录酶抑制剂的副作用

PIN24 IMPROVEMENT IN PATIENT-REPORTED DEPRESSION IN HIV+ PATIENTS EXPERIENCING GRADE 2 SIDE EFFECTS AFTER SUBSTITUTION OF THEIR PROTEASE INHIBITOR (PI)/NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR (NNRTI) WITH LOPINAVIR/RITONAVIR (LPV/R)

著录项

相似文献

相关主题

期刊订阅